ClinicalTrials.govpublic full text
A Study to Assess Intravenous (IV) Telisotuzumab Adizutecan in Combination With Fluorouracil, Folinic Acid, and Oxaliplatin (FOLFOX) Compared to Standard of Care in Adult Participants With First-Line Metastatic Pancreatic Ductal Adenocarcinoma
metastatic pancreatic ductal adenocarcinoma, pdac, telisotuzumab adizutecan, interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 803887
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.